SLXN EFFECT: Shelf registration
Filed with the SEC on · accession 9999999995-26-003485
SLXN filed a EFFECT (effect) with the SEC on Nov 9, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -16.7% by the first close after the filing.
Summary of the filing
The SEC declared effective Silexion Therapeutics Corp's Form S-3 shelf registration statement (File No. 333-299675) on November 9, 2026, allowing the company to offer and sell securities from time to time.
Key details
How SLXN stock reacted
Close before
$3.57
Nov 6, 2026
First close after
-16.73%
$2.97
5 trading days
—
Since filing
-24.95%
$2.68
✦ Ask GOAX AI about this filing — what it means for SLXN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SLXN?
Click hereFrequently asked questions
What did SLXN file with the SEC on Nov 9, 2026?
SLXN filed a EFFECT (Shelf registration). The SEC declared effective Silexion Therapeutics Corp's Form S-3 shelf registration statement (File No. 333-299675) on November 9, 2026, allowing the company to offer and sell securities from time to time.
What does a shelf registration mean for SLXN stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a EFFECT?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A EFFECT (effect): A report the company filed with the SEC (the US market regulator).
How did SLXN stock react to this filing?
SLXN closed at $3.57 before the filing and $2.97 on Nov 9, 2026 (-16.73%).
Other SLXN SEC filings
- 10-Q · SEC filingNov 12, 2026
- 8-K · Stock splitNov 12, 2026
- 8-K · Stock splitNov 9, 2026
- S-3 · Shelf registrationOct 28, 2026
- 8-K · SEC filingOct 26, 2026
- DEF 14A · Stock splitOct 5, 2026
- 8-K · Fda approvalSep 30, 2026
- 424B3 · Secondary offeringSep 29, 2026
- 8-K · SEC filingSep 29, 2026
- SCHEDULE 13D/A · Activist campaignSep 28, 2026
Get alerts when SLXN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days